Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis

In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 14; no. 9; p. e0221484
Main Authors Magele, Astrid, Schoerg, Philipp, Stanek, Barbara, Gradl, Bernhard, Sprinzl, Georg Mathias
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 16.09.2019
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes. Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis. 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment. The device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
AbstractList In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes. Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis. 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment. The device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
Background In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. Objectives To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Data sources Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. Study eligibility criteria Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes. Study appraisal and synthesis methods Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis. Results 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. Limitations A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment. Conclusion The device’s transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device’s indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. The device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
Background In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. Objectives To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Data sources Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. Study eligibility criteria Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes. Study appraisal and synthesis methods Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis. Results 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. Limitations A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment. Conclusion The device’s transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device’s indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems.BACKGROUNDIn July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems.To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device.OBJECTIVESTo critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device.Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies.DATA SOURCESLiterature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies.Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes.STUDY ELIGIBILITY CRITERIARandomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes.Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis.STUDY APPRAISAL AND SYNTHESIS METHODSRetrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis.39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation.RESULTS39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation.A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment.LIMITATIONSA limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment.The device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).CONCLUSIONThe device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
BackgroundIn July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems.ObjectivesTo critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device.Data sourcesLiterature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies.Study eligibility criteriaRandomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes.Study appraisal and synthesis methodsRetrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis.Results39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation.LimitationsA limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment.ConclusionThe device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).
Audience Academic
Author Sprinzl, Georg Mathias
Magele, Astrid
Schoerg, Philipp
Stanek, Barbara
Gradl, Bernhard
AuthorAffiliation 1 University Clinic St. Poelten, Department of Otorhinolaryngology, Head & Neck Surgery, St. Poelten, Austria
University of Miami School of Medicine, UNITED STATES
2 Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria
AuthorAffiliation_xml – name: 1 University Clinic St. Poelten, Department of Otorhinolaryngology, Head & Neck Surgery, St. Poelten, Austria
– name: 2 Karl Landsteiner Institute of Implantable Hearing Devices, St. Poelten, Austria
– name: University of Miami School of Medicine, UNITED STATES
Author_xml – sequence: 1
  givenname: Astrid
  surname: Magele
  fullname: Magele, Astrid
– sequence: 2
  givenname: Philipp
  surname: Schoerg
  fullname: Schoerg, Philipp
– sequence: 3
  givenname: Barbara
  surname: Stanek
  fullname: Stanek, Barbara
– sequence: 4
  givenname: Bernhard
  surname: Gradl
  fullname: Gradl, Bernhard
– sequence: 5
  givenname: Georg Mathias
  orcidid: 0000-0003-4936-1424
  surname: Sprinzl
  fullname: Sprinzl, Georg Mathias
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31525208$$D View this record in MEDLINE/PubMed
BookMark eNqNk12L1DAUhousuB_6D0QLgujFjGm-2uyFMCx-DCwsuOqNFyFNT2cytMlsk47OvzfjdGS6LCK9aDl5zptz3p5znpxYZyFJnmdompE8e7dyfWdVM13H8BRhnNGCPkrOMkHwhGNETo6-T5Nz71cIMVJw_iQ5JRnDDKPiLPkx08FsIA2dsl73QVlwvU_LKJpqZ6s-HjubLkF1xi5S064bZYO_TG-3PkCrgtFpBxsDP1Nlq7SFoCYqlrX1xj9NHteq8fBseF8k3z5--Hr1eXJ982l-Nbue6JwVYcIZ54hXgvCyyOtYo8grKJjOtQJai4rosuZ5CTngkmeooFXNlaIlFkJhWlbkInm51103zsvBFy8xFhlhLGcoEvM9UTm1kuvOtKrbSqeM_BNw3UKqLrbSgKSqQLXSGRZ1FFdFWVFGNdCcE8AMdNR6P9zWly1UGmz0rhmJjk-sWcqF20ieU04EiwJvBoHO3fXgg2yN19A0e-93dWMkMOE0oq_uoQ93N1ALFRswtnbxXr0TlTMmRI5p7CZS0weo-FTQmviroTYxPkp4O0qITIBfYaF67-X89sv_szffx-zrIzZOVhOW3jX9btD8GHxx7PRfiw_TG4HLPaA7530HtdQmqJ1ObM00MkNytyoH0-RuVeSwKjGZ3ks-6P8z7TekmBkV
CitedBy_id crossref_primary_10_1016_j_amjoto_2021_102968
crossref_primary_10_1002_ohn_728
crossref_primary_10_1177_0003489420924058
crossref_primary_10_1055_s_0040_1715152
crossref_primary_10_3390_life12020137
crossref_primary_10_1007_s00106_020_00877_2
crossref_primary_10_3390_ijerph19052503
crossref_primary_10_1007_s00405_022_07752_6
crossref_primary_10_1016_j_ijporl_2025_112272
crossref_primary_10_3390_jmahp12010003
crossref_primary_10_1002_lio2_70010
crossref_primary_10_1186_s13063_021_05160_5
crossref_primary_10_1109_ACCESS_2020_2994323
crossref_primary_10_1097_MAO_0000000000003230
crossref_primary_10_1007_s00405_023_07889_y
crossref_primary_10_1111_coa_13556
crossref_primary_10_3390_app13148279
crossref_primary_10_1016_j_otot_2024_01_011
crossref_primary_10_1007_s00405_020_06022_7
crossref_primary_10_3390_jcm10245916
crossref_primary_10_1016_j_xocr_2022_100423
crossref_primary_10_7759_cureus_72047
crossref_primary_10_1016_j_anl_2022_09_003
crossref_primary_10_1016_j_heares_2021_108424
crossref_primary_10_1177_00034894241283269
crossref_primary_10_1007_s00405_021_07031_w
crossref_primary_10_1097_MAO_0000000000003159
crossref_primary_10_1097_MOO_0000000000000653
crossref_primary_10_1097_MAO_0000000000003045
crossref_primary_10_1097_MAO_0000000000004057
crossref_primary_10_1097_MAO_0000000000004453
crossref_primary_10_1097_MAO_0000000000002794
crossref_primary_10_3342_kjorl_hns_2019_00773
crossref_primary_10_1177_01945998211044408
crossref_primary_10_3390_audiolres14050075
crossref_primary_10_1097_MAO_0000000000003681
crossref_primary_10_1177_01455613231154045
crossref_primary_10_1017_S0022215122000494
crossref_primary_10_1007_s00106_020_00876_3
crossref_primary_10_1177_2473974X20932506
crossref_primary_10_1002_ohn_791
crossref_primary_10_1007_s00405_021_07068_x
crossref_primary_10_1097_AUD_0000000000001088
crossref_primary_10_3389_fauot_2024_1362443
crossref_primary_10_1097_MAO_0000000000003447
crossref_primary_10_1080_14992027_2021_1966704
crossref_primary_10_1109_ACCESS_2023_3247738
crossref_primary_10_1007_s00405_022_07631_0
crossref_primary_10_1007_s00405_021_06626_7
crossref_primary_10_1007_s00405_025_09335_7
crossref_primary_10_3390_jpm14010081
crossref_primary_10_1177_00368504251328010
crossref_primary_10_1111_coa_13659
crossref_primary_10_1002_lary_31053
crossref_primary_10_1007_s00405_022_07265_2
crossref_primary_10_1016_j_amjoto_2024_104513
crossref_primary_10_1109_ACCESS_2021_3099305
crossref_primary_10_1016_j_heares_2022_108503
crossref_primary_10_1001_jamaoto_2021_2769
crossref_primary_10_1080_14670100_2024_2398833
crossref_primary_10_1002_lio2_1030
crossref_primary_10_1017_S0022215122001839
Cites_doi 10.1097/MAO.0000000000001038
10.1159/000371425
10.3109/00016489.2016.1143119
10.1097/MAO.0000000000000830
10.1586/17434440.2015.990375
10.1016/j.ijporl.2014.02.004
10.5152/iao.2015.1341
10.1016/j.anl.2013.04.004
10.1136/bmj.327.7414.557
10.18637/jss.v036.i03
10.1016/j.ijporl.2017.08.008
10.1097/MAO.0000000000001327
10.1097/MAO.0b013e31827d07f3
10.1177/2331216516669330
10.5606/kbbihtisas.2014.45143
10.1097/MAO.0b013e31828bb541
10.1097/MAO.0000000000000405
10.1016/j.ijporl.2018.01.032
10.1097/MAO.0000000000000712
10.1097/MAO.0000000000001328
10.1097/MAO.0000000000000208
10.1016/j.ijporl.2014.12.032
10.1007/s00330-015-3983-x
10.1016/j.ijporl.2015.03.031
10.12659/AJCR.904907
10.3109/00016489.2014.1003091
10.1097/MAO.0b013e318241c0bf
10.1097/MAO.0000000000001394
10.1097/MAO.0000000000001010
10.1017/S0022215109991708
10.1111/coa.12484
10.1097/MAO.0000000000001809
10.1097/MAO.0000000000000695
10.1007/s00405-017-4614-8
10.1097/MAO.0000000000000842
10.3109/00016489.2013.799293
10.1002/lary.24832
10.1097/MAO.0000000000000733
10.1017/S0022215113002144
10.1017/S0022215118001123
10.1097/MAO.0000000000000791
10.1111/coa.12793
10.1016/j.ijporl.2015.07.021
10.1097/MAO.0000000000000351
10.1097/MAO.0000000000000253
10.1016/j.ijporl.2017.01.018
10.1080/00016489.2016.1258733
ContentType Journal Article
Copyright COPYRIGHT 2019 Public Library of Science
2019 Magele et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 Magele et al 2019 Magele et al
Copyright_xml – notice: COPYRIGHT 2019 Public Library of Science
– notice: 2019 Magele et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 Magele et al 2019 Magele et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0221484
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database (ProQuest)
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Agricultural Science Database




MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Bonebridge: Review and meta-analysis
EISSN 1932-6203
ExternalDocumentID 2291355750
oai_doaj_org_article_4a80fac129f24ba8bd454ce4763e25ec
PMC6746395
A599724129
31525208
10_1371_journal_pone_0221484
Genre Meta-Analysis
Systematic Review
Journal Article
GeographicLocations United States
United Kingdom--UK
Austria
GeographicLocations_xml – name: United States
– name: Austria
– name: United Kingdom--UK
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
BBAFP
N95
ID FETCH-LOGICAL-c758t-656606d936b87f05397de85c7cae4f9d3cbf67be7e2b61084df6aa4b299a24bd3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Nov 06 00:11:10 EDT 2022
Wed Aug 27 01:12:23 EDT 2025
Thu Aug 21 14:21:55 EDT 2025
Tue Aug 05 10:09:15 EDT 2025
Fri Jul 25 10:09:12 EDT 2025
Tue Jun 17 21:25:04 EDT 2025
Tue Jun 10 20:46:20 EDT 2025
Fri Jun 27 04:25:09 EDT 2025
Fri Jun 27 05:05:29 EDT 2025
Thu May 22 21:21:15 EDT 2025
Wed Feb 19 02:30:39 EST 2025
Tue Jul 01 02:13:08 EDT 2025
Thu Apr 24 23:05:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-656606d936b87f05397de85c7cae4f9d3cbf67be7e2b61084df6aa4b299a24bd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0003-4936-1424
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0221484
PMID 31525208
PQID 2291355750
PQPubID 1436336
PageCount e0221484
ParticipantIDs plos_journals_2291355750
doaj_primary_oai_doaj_org_article_4a80fac129f24ba8bd454ce4763e25ec
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6746395
proquest_miscellaneous_2292092364
proquest_journals_2291355750
gale_infotracmisc_A599724129
gale_infotracacademiconefile_A599724129
gale_incontextgauss_ISR_A599724129
gale_incontextgauss_IOV_A599724129
gale_healthsolutions_A599724129
pubmed_primary_31525208
crossref_citationtrail_10_1371_journal_pone_0221484
crossref_primary_10_1371_journal_pone_0221484
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-09-16
PublicationDateYYYYMMDD 2019-09-16
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-16
  day: 16
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2019
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References S. Zhao (pone.0221484.ref039) 2016; 136
A. Jovankovicova (pone.0221484.ref047) 2015; 79
M. Barbara (pone.0221484.ref016) 2013; 133
S. Monini (pone.0221484.ref044) 2017; 137
P.J. Clamp (pone.0221484.ref055) 2015; 12
J.W. Rainsbury (pone.0221484.ref034) 2015; 36
H.R. Powell (pone.0221484.ref058) 2015; 36
F. Ihler (pone.0221484.ref023) 2016; 20
W. Wimmer (pone.0221484.ref015) 2015; 272
T. Gerdes (pone.0221484.ref022) 2016
S. Schmerber (pone.0221484.ref045) 2016
T. Gerdes (pone.0221484.ref040) 2016; 37
E. Vyskocil (pone.0221484.ref014) 2017; 42
J. Kulasegarah (pone.0221484.ref008) 2018; 107
J. Schnabl (pone.0221484.ref019) 2014; 35
S.D. Carr (pone.0221484.ref054) 2015; 36
A. Centric (pone.0221484.ref059) 2014; 78
M. Iseri (pone.0221484.ref057) 2015; 36
M.E. Zernotti (pone.0221484.ref046) 2016; 136
G. Bianchin (pone.0221484.ref027) 2015; 77
W. Viechtbauer (pone.0221484.ref004) 2010; 36
E.K. Law (pone.0221484.ref011) 2016; 26
S.D. Carr (pone.0221484.ref063) 2015; 36
D.D. Hougaard (pone.0221484.ref064) 2017; 274
G.M. Sprinzl (pone.0221484.ref001) 2016; 41
R. Weiss (pone.0221484.ref043) 2016
C. Der (pone.0221484.ref006) 2018; 39
K.E. Eberhard (pone.0221484.ref007) 2016; 37
M. Manrique (pone.0221484.ref025) 2014; 35
S.Y. Chen (pone.0221484.ref051) 2017; 38
J.P. Higgins (pone.0221484.ref005) 2003; 327
RStudio Team (pone.0221484.ref003) 2015
R. Briggs (pone.0221484.ref053) 2015; 36
S.K. Plontke (pone.0221484.ref032) 2014; 35
L.X. Ngui (pone.0221484.ref017) 2018; 132
L. Lassaletta (pone.0221484.ref031) 2014; 41
T. Rahne (pone.0221484.ref033) 2015; 272
W.D. Baumgartner (pone.0221484.ref026) 2016; 37
W.S. Tsang (pone.0221484.ref036) 2013; 127
F. Ihler (pone.0221484.ref041) 2016; 20
B.G. Weiss (pone.0221484.ref037) 2017; 274
J.C. Hobson (pone.0221484.ref048) 2010; 124
R.D. Laske (pone.0221484.ref009) 2015; 36
F. Ihler (pone.0221484.ref024) 2014; 35
R. Weiss (pone.0221484.ref038) 2017; 274
M. Kim (pone.0221484.ref030) 2015; 11
M. Iseri (pone.0221484.ref065) 2015; 36
E. Vyskocil (pone.0221484.ref020) 2017; 38
D. Zanetti (pone.0221484.ref021) 2018; 19
F. Denoyelle (pone.0221484.ref060) 2015; 79
G. Sprinzl (pone.0221484.ref035) 2013; 34
F. Denoyelle (pone.0221484.ref061) 2013; 34
PA Dimitriadis (pone.0221484.ref066) 2017; 94
X. Fan (pone.0221484.ref028) 2017; 101
L. Lassaletta (pone.0221484.ref010) 2016; 273
S. Schmerber (pone.0221484.ref013) 2017; 274
C.A. Dun (pone.0221484.ref050) 2012; 33
R. Salcher (pone.0221484.ref012) 2017; 38
E. Vyskocil (pone.0221484.ref042) 2017
F. Hassepass (pone.0221484.ref029) 2015; 272
R Core Team (pone.0221484.ref002) 2016
R.C. Nelissen (pone.0221484.ref049) 2013; 270
M. Iseri (pone.0221484.ref056) 2014; 24
R. Briggs (pone.0221484.ref062) 2015; 36
D. Riss (pone.0221484.ref018) 2014; 124
S. Baker (pone.0221484.ref052) 2015; 79
References_xml – volume: 37
  start-page: 713
  issue: 6
  year: 2016
  ident: pone.0221484.ref026
  article-title: A New Transcutaneous Bone Conduction Hearing Implant: Short-term Safety and Efficacy in Children
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001038
– volume: 77
  start-page: 17
  issue: 1
  year: 2015
  ident: pone.0221484.ref027
  article-title: Active bone conduction system: outcomes with the Bonebridge transcutaneous device
  publication-title: ORL; journal for oto-rhino-laryngology and its related specialties
  doi: 10.1159/000371425
– volume: 136
  start-page: 556
  issue: 6
  year: 2016
  ident: pone.0221484.ref046
  article-title: Comparative outcomes of active and passive hearing devices by transcutaneous bone conduction
  publication-title: Acta oto-laryngologica
  doi: 10.3109/00016489.2016.1143119
– volume: 36
  start-page: 1399
  issue: 8
  year: 2015
  ident: pone.0221484.ref063
  article-title: Initial UK Experience With a Novel Magnetic Transcutaneous Bone Conduction Device
  publication-title: Otol Neurotol
  doi: 10.1097/MAO.0000000000000830
– volume: 12
  start-page: 223
  issue: 3
  year: 2015
  ident: pone.0221484.ref055
  article-title: The Cochlear Baha 4 Attract System—design concepts, surgical technique and early clinical results
  publication-title: Expert review of medical devices
  doi: 10.1586/17434440.2015.990375
– volume: 78
  start-page: 875
  issue: 5
  year: 2014
  ident: pone.0221484.ref059
  article-title: Abutment-free bone-anchored hearing devices in children: initial results and experience
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2014.02.004
– start-page: 1
  year: 2016
  ident: pone.0221484.ref043
  article-title: Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device Bonebridge
  publication-title: European Archives of Oto-Rhino-Laryngology
– volume: 36
  start-page: 1399
  issue: 8
  year: 2015
  ident: pone.0221484.ref054
  article-title: Initial UK Experience With a Novel Magnetic Transcutaneous Bone Conduction Device
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000830
– volume: 11
  start-page: 163
  issue: 2
  year: 2015
  ident: pone.0221484.ref030
  article-title: Bonebridge Implantation for Conductive Hearing Loss in a Patient with Oval Window Atresia
  publication-title: The journal of international advanced otology
  doi: 10.5152/iao.2015.1341
– volume: 41
  start-page: 84
  issue: 1
  year: 2014
  ident: pone.0221484.ref031
  article-title: Retrosigmoid implantation of an active bone conduction stimulator in a patient with chronic otitis media
  publication-title: Auris, nasus, larynx
  doi: 10.1016/j.anl.2013.04.004
– volume: 327
  start-page: 557
  issue: 7414
  year: 2003
  ident: pone.0221484.ref005
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
– volume: 36
  start-page: 48
  issue: 3
  year: 2010
  ident: pone.0221484.ref004
  article-title: Conducting Meta-Analyses in R with the metafor Package
  publication-title: Journal of Statistical Software
  doi: 10.18637/jss.v036.i03
– volume: 101
  start-page: 150
  year: 2017
  ident: pone.0221484.ref028
  article-title: Aesthetic and hearing rehabilitation in patients with bilateral microtia-atresia
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2017.08.008
– volume: 38
  start-page: 364
  issue: 3
  year: 2017
  ident: pone.0221484.ref051
  article-title: Skin Necrosis After Implantation With the BAHA Attract: A Case Report and Review of the Literature
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001327
– volume: 34
  start-page: 275
  issue: 2
  year: 2013
  ident: pone.0221484.ref061
  article-title: New closed skin bone-anchored implant: preliminary results in 6 children with ear atresia
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0b013e31827d07f3
– volume: 20
  year: 2016
  ident: pone.0221484.ref041
  article-title: The Prediction of Speech Recognition in Noise With a Semi-Implantable Bone Conduction Hearing System by External Bone Conduction Stimulation With Headband: A Prospective Study
  publication-title: Trends in Hearing
  doi: 10.1177/2331216516669330
– volume: 24
  start-page: 59
  issue: 2
  year: 2014
  ident: pone.0221484.ref056
  article-title: A new transcutaneous bone anchored hearing device—the Baha(R) Attract System: the first experience in Turkey
  publication-title: Kulak burun bogaz ihtisas dergisi: KBB = Journal of ear, nose, and throat
  doi: 10.5606/kbbihtisas.2014.45143
– volume: 34
  start-page: 1076
  issue: 6
  year: 2013
  ident: pone.0221484.ref035
  article-title: First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0b013e31828bb541
– volume: 37
  start-page: 267
  issue: 3
  year: 2016
  ident: pone.0221484.ref007
  article-title: Objective and Subjective Outcome of a New Transcutaneous Bone Conduction Hearing Device: Half-year Follow-up of the First 12 Nordic Implantations
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
– volume: 35
  start-page: 1251
  issue: 7
  year: 2014
  ident: pone.0221484.ref032
  article-title: Individual computer-assisted 3D planning for surgical placement of a new bone conduction hearing device
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000405
– volume-title: RStudio: Integrated Development for R
  year: 2015
  ident: pone.0221484.ref003
– volume: 107
  start-page: 176
  year: 2018
  ident: pone.0221484.ref008
  article-title: Comparing audiological outcomes between the Bonebridge and bone conduction hearing aid on a hard test band: Our experience in children with atresia and microtia
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2018.01.032
– volume: 36
  start-page: 834
  issue: 5
  year: 2015
  ident: pone.0221484.ref053
  article-title: Clinical performance of a new magnetic bone conduction hearing implant system: results from a prospective, multicenter, clinical investigation
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000712
– volume: 272
  start-page: 1651
  issue: 7
  year: 2015
  ident: pone.0221484.ref015
  article-title: Topographic bone thickness maps for Bonebridge implantations
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 273
  start-page: 4103
  issue: 12
  year: 2016
  ident: pone.0221484.ref010
  article-title: Postoperative pain in patients undergoing a transcutaneous active bone conduction implant (Bonebridge)
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 38
  start-page: 318
  issue: 3
  year: 2017
  ident: pone.0221484.ref020
  article-title: Sound Localization in Patients With Congenital Unilateral Conductive Hearing Loss With a Transcutaneous Bone Conduction Implant
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001328
– volume: 35
  start-page: 211
  issue: 2
  year: 2014
  ident: pone.0221484.ref024
  article-title: Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000208
– volume: 274
  start-page: 1835
  issue: 4
  year: 2017
  ident: pone.0221484.ref013
  article-title: Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 79
  start-page: 382
  issue: 3
  year: 2015
  ident: pone.0221484.ref060
  article-title: Hearing rehabilitation with the closed skin bone-anchored implant Sophono Alpha1: results of a prospective study in 15 children with ear atresia
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2014.12.032
– volume: 26
  start-page: 1686
  issue: 6
  year: 2016
  ident: pone.0221484.ref011
  article-title: CT pre-operative planning of a new semi-implantable bone conduction hearing device
  publication-title: European radiology
  doi: 10.1007/s00330-015-3983-x
– volume: 79
  start-page: 975
  issue: 7
  year: 2015
  ident: pone.0221484.ref047
  article-title: Surgery or implantable hearing devices in children with congenital aural atresia: 25 years of our experience
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2015.03.031
– volume: 19
  start-page: 82
  year: 2018
  ident: pone.0221484.ref021
  article-title: A Bone Conduction Implantable Device as a Functional Treatment Option in Unilateral Microtia with Bilateral Stapes Ankylosis: A Report of Two Cases
  publication-title: The American journal of case reports
  doi: 10.12659/AJCR.904907
– volume: 20
  year: 2016
  ident: pone.0221484.ref023
  article-title: The Prediction of Speech Recognition in Noise With a Semi-Implantable Bone Conduction Hearing System by External Bone Conduction Stimulation With Headband: A Prospective Study
  publication-title: Trends in hearing
  doi: 10.1177/2331216516669330
– volume: 136
  start-page: 23
  issue: 1
  year: 2016
  ident: pone.0221484.ref039
  article-title: Round window application of an active middle ear implant (AMEI) system in congenital oval window atresia
  publication-title: Acta oto-laryngologica
  doi: 10.3109/00016489.2014.1003091
– volume: 272
  start-page: 3263
  issue: 11
  year: 2015
  ident: pone.0221484.ref033
  article-title: Functional results after Bonebridge implantation in adults and children with conductive and mixed hearing loss
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 33
  start-page: 192
  issue: 2
  year: 2012
  ident: pone.0221484.ref050
  article-title: Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0b013e318241c0bf
– volume: 36
  start-page: 834
  issue: 5
  year: 2015
  ident: pone.0221484.ref062
  article-title: Clinical performance of a new magnetic bone conduction hearing implant system: results from a prospective, multicenter, clinical investigation
  publication-title: Otol Neurotol
  doi: 10.1097/MAO.0000000000000712
– volume: 38
  start-page: 642
  issue: 5
  year: 2017
  ident: pone.0221484.ref012
  article-title: Audiological Results in SSD With an Active Transcutaneous Bone Conduction Implant at a Retrosigmoidal Position
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001394
– volume: 37
  start-page: 685
  issue: 6
  year: 2016
  ident: pone.0221484.ref040
  article-title: Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001010
– volume: 124
  start-page: 132
  issue: 2
  year: 2010
  ident: pone.0221484.ref048
  article-title: Complications of bone-anchored hearing aid implantation
  publication-title: The Journal of laryngology and otology
  doi: 10.1017/S0022215109991708
– volume: 41
  start-page: 131
  issue: 2
  year: 2016
  ident: pone.0221484.ref001
  article-title: The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature
  publication-title: Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
  doi: 10.1111/coa.12484
– volume: 39
  start-page: e342
  issue: 5
  year: 2018
  ident: pone.0221484.ref006
  article-title: Active Transcutaneous Bone Conduction Implant: Middle Fossa Placement Technique in Children With Bilateral Microtia and External Auditory Canal Atresia
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000001809
– volume: 36
  start-page: e58
  issue: 2
  year: 2015
  ident: pone.0221484.ref034
  article-title: Preoperative headband assessment for semi-implantable bone conduction hearing devices in conductive hearing loss: is it useful or misleading?
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000695
– volume: 274
  start-page: 3011
  issue: 8
  year: 2017
  ident: pone.0221484.ref064
  article-title: A multicenter study on objective and subjective benefits with a transcutaneous bone-anchored hearing aid device: first Nordic results
  publication-title: Eur Arch Otorhinolaryngol
  doi: 10.1007/s00405-017-4614-8
– volume: 270
  start-page: 3019
  issue: 12
  year: 2013
  ident: pone.0221484.ref049
  article-title: A new bone-anchored hearing implant: short-term retrospective data on implant survival and subjective benefit
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 36
  start-page: 1525
  issue: 9
  year: 2015
  ident: pone.0221484.ref058
  article-title: A Comparative Study of Audiologic Outcomes for Two Transcutaneous Bone-Anchored Hearing Devices
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000842
– volume: 133
  start-page: 1058
  issue: 10
  year: 2013
  ident: pone.0221484.ref016
  article-title: Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss
  publication-title: Acta oto-laryngologica
  doi: 10.3109/00016489.2013.799293
– year: 2017
  ident: pone.0221484.ref042
  article-title: Sound Localization in Patients With Congential Unilateral Conductive Hearing Loss With a Transcutaneous Bone Conduction Implant
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
– volume: 272
  start-page: 2235
  issue: 9
  year: 2015
  ident: pone.0221484.ref029
  article-title: The bonebridge as a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 124
  start-page: 2802
  issue: 12
  year: 2014
  ident: pone.0221484.ref018
  article-title: Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant
  publication-title: The Laryngoscope
  doi: 10.1002/lary.24832
– volume: 36
  start-page: 849
  issue: 5
  year: 2015
  ident: pone.0221484.ref057
  article-title: Transcutaneous Bone-anchored Hearing Aids Versus Percutaneous Ones: Multicenter Comparative Clinical Study
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000733
– volume: 274
  start-page: 2107
  issue: 5
  year: 2017
  ident: pone.0221484.ref038
  article-title: Improvement of speech perception in quiet and in noise without decreasing localization abilities with the bone conduction device Bonebridge
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 127
  start-page: 1214
  issue: 12
  year: 2013
  ident: pone.0221484.ref036
  article-title: The Bonebridge semi-implantable bone conduction hearing device: experience in an Asian patient
  publication-title: The Journal of laryngology and otology
  doi: 10.1017/S0022215113002144
– volume: 132
  start-page: 693
  issue: 8
  year: 2018
  ident: pone.0221484.ref017
  article-title: Bonebridge transcutaneous bone conduction implant in children with congenital aural atresia: surgical and audiological outcomes
  publication-title: The Journal of laryngology and otology
  doi: 10.1017/S0022215118001123
– year: 2016
  ident: pone.0221484.ref022
  article-title: Comparison of Audiological Results Between a Transcutaneous and a Percutaneous Bone Conduction Instrument in Conductive Hearing Loss
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
– volume: 36
  start-page: 849
  issue: 5
  year: 2015
  ident: pone.0221484.ref065
  article-title: Transcutaneous Bone-anchored Hearing Aids Versus Percutaneous Ones: Multicenter Comparative Clinical Study
  publication-title: Otol Neurotol
  doi: 10.1097/MAO.0000000000000733
– volume: 36
  start-page: 1151
  issue: 7
  year: 2015
  ident: pone.0221484.ref009
  article-title: Functional Results and Subjective Benefit of a Transcutaneous Bone Conduction Device in Patients With Single-Sided Deafness
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000791
– year: 2016
  ident: pone.0221484.ref045
  article-title: Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume: 42
  start-page: 1033
  issue: 5
  year: 2017
  ident: pone.0221484.ref014
  article-title: Dura and sinus compression with a transcutaneous bone conduction device—hearing outcomes and safety in 38 patients
  publication-title: Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
  doi: 10.1111/coa.12793
– volume: 79
  start-page: 1667
  issue: 10
  year: 2015
  ident: pone.0221484.ref052
  article-title: Innovation in abutment-free bone-anchored hearing devices in children: Updated results and experience
  publication-title: International journal of pediatric otorhinolaryngology
  doi: 10.1016/j.ijporl.2015.07.021
– volume: 35
  start-page: 1242
  issue: 7
  year: 2014
  ident: pone.0221484.ref019
  article-title: Intraoperative measurement for a new transcutaneous bone conduction hearing implant
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000351
– volume: 35
  start-page: 216
  issue: 2
  year: 2014
  ident: pone.0221484.ref025
  article-title: A new bone conduction implant: surgical technique and results
  publication-title: Otology & neurotology: official publication of the American Otological Society, American Neurotology Society and European Academy of Otology and Neurotology
  doi: 10.1097/MAO.0000000000000253
– volume: 274
  start-page: 3001
  issue: 8
  year: 2017
  ident: pone.0221484.ref037
  article-title: Systematic radiographic evaluation of three potential implantation sites for a semi-implantable bone conduction device in 52 patients after previous mastoid surgery
  publication-title: European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology—Head and Neck Surgery
– volume-title: R: A language and environment for statistical computing
  year: 2016
  ident: pone.0221484.ref002
– volume: 94
  start-page: 59
  year: 2017
  ident: pone.0221484.ref066
  article-title: Intermediate outcomes of a transcutaneous bone conduction hearing device in a paediatric population
  publication-title: International Journal of Pediatric Otorhinolaryngology
  doi: 10.1016/j.ijporl.2017.01.018
– volume: 137
  start-page: 389
  issue: 4
  year: 2017
  ident: pone.0221484.ref044
  article-title: Patient satisfaction after auditory implant surgery: ten-year experience from a single implanting unit center
  publication-title: Acta oto-laryngologica
  doi: 10.1080/00016489.2016.1258733
RelatedPersons Landsteiner, Karl
RelatedPersons_xml – fullname: Landsteiner, Karl
SSID ssj0053866
Score 2.5302386
SecondaryResourceType review_article
Snippet In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or...
Background In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with...
BackgroundIn July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with...
Background In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0221484
SubjectTerms Biology and Life Sciences
Bone Conduction
Bone implants
Case reports
Clinical trials
Cochlear Implants - adverse effects
Cochlear Implants - psychology
Complications
Conduction
Conductivity
Deafness
Engineering and Technology
Evaluation
Hearing aids
Hearing loss
Humans
Implantation
Incidence
Integer programming
Landsteiner, Karl
Language
Localization
Medical equipment
Medical research
Medicine and Health Sciences
Meta-analysis
Noise
Online searching
Otolaryngology
Otology
Patient Satisfaction
Patients
Pattern recognition
Pediatrics
Physical Sciences
Randomized Controlled Trials as Topic
Recognition
Research and Analysis Methods
Safety and security measures
Sensitivity analysis
Skin
Social Sciences
Stability analysis
Studies
Subgroups
Surgery
Systematic review
Technology
Transplants & implants
Words (language)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBFgxCAg5ps7FjJ9wWRFWQAIlSVImD5Veg0ja7arL_nxnbGzWoUjmwx_V45Z2HZ0ae-YaQl21lNKsrmwuHI8wMY_hIqHNnHHwKuAAZNid__iKOT_mns-rsyqgvrAmL8MCRcYdc10WrLbiltuRG18bxilvPwS58WXmLty_4vG0yFe9gsGIhUqMck_PDJJeD9arzB-C1IAfgE0cU8PrHW3m2Xq7660LOvysnr7iio7vkTooh6SKefYfc8t09spOstKevE5T0m_vk5yJcZ3RAj2Q3EAh6yPSpgQNSSIRdhI6lONUaXBg9v1gvsS7mLT0ZAZ5pbG6hunP0wg861wnG5AE5Pfrw_f1xnsYp5BaSgiHHyK0QrmHC1LIFHjXSeRCTtNrztnHMmlZI46UvDQRVNXet0JobkJcG1jv2kMw6ON8uoTK8rlVFYYGsLKoaclo7rwvOG-Fc02SEbXmrbMIax5EXSxUe0CTkHJFVCiWikkQyko-71hFr4wb6dyi2kRaRssMXoD8q6Y-6SX8y8gyFrmLb6WjvalFhSzGHfRl5ESgQLaPDcpxfetP36uPXH_9AdPJtQvQqEbUrYIfVqQUC_hOicE0o9yaUYPN2sryLKrrlSq_KsplD5AjhH-zcqu31y8_HZfxRLLELqoc0YEg4TyAjj6KWj5xlOCWrLOqMyIn-T1g_XenOfwewciE5BMHV4_8hqyfkNsSrocRvLvbIbLjc-H2ICQfzNJj_HynRYU4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9QwDI_geOEFMb5W2CAgJOChW69Jk5YXdCCmgQRIjKGTeKjy1W3SrS1r7_-fneYKRRNwj41zSu04thv7Z0KeV5lWLM9MLCy2MNOM4SWhiq228EvgAGRYnPzpszg85h-X2TJ8cOtCWuXmTPQHtW0MfiPfT9NiDrYRDNyb9meMXaPwdjW00LhObiB0GaZ0yeUYcIEuCxHK5Zic7wfp7LVN7fbAdkEkwCfmyKP2j2fzrF013VWO55_5k78ZpIPb5FbwJOliEP0WuebqO2Qr6GpHXwZA6Vd3yY-FP9Roj3bJrMEddBDvUw0LpBAO2wFAlmJvazBk9Oy8XWF2zGt6NMI806HEhara0nPXq1gFMJN75Pjg_bd3h3FoqhAbCA36GP23RNiCCZ3LCnhUSOtAWNIox6vCMqMrIbWTLtXgWuXcVkIprkFqKuXasvtkVsP6tgmV_o4tSxIDZGmS5RDZmnmecF4Ia4siImzD29IExHFsfLEq_TWahMhjYFWJEimDRCISj7PaAXHjH_RvUWwjLeJl-wfNxUkZ1K_kKk8qZcC5qeAlVK4tz7hxHE5Xl2bOROQJCr0cik9HrS8XGRYWc5gXkWeeAjEzakzKOVHrris_fPn-H0RHXydELwJR1QA7jAqFEPBOiMU1odyZUILmm8nwNm7RDVe68peOwMzNtr16-Ok4jH-KiXZ-6yFNmhTYVSAiD4ZdPnKWYa-sNMkjIif7f8L66Uh9duohy4Xk4ApnD_--rEfkJvijPoVvLnbIrL9Yu13w-Xr92Cv2JemSV_0
  priority: 102
  providerName: ProQuest
Title Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/31525208
https://www.proquest.com/docview/2291355750
https://www.proquest.com/docview/2292092364
https://pubmed.ncbi.nlm.nih.gov/PMC6746395
https://doaj.org/article/4a80fac129f24ba8bd454ce4763e25ec
http://dx.doi.org/10.1371/journal.pone.0221484
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELe27oUXxPha2CgGIQEPqfLhxAkSQt20MpA20EZRJR4if2VM6tKuaSX477lz3IigIqAPeajPUXJ3vvtd7Lsj5HmZSBFnifJTjS3MZBzjJqHwtdTwC8AAxpicfHqWnozZh0ky2SLrnq2OgfXG0A77SY0X08H3mx9vYcG_sV0beLieNJjPKjMAnwQIn22THfBNHJfqKWv3FWB1291LRC1-GgWxS6b70106zsrW9G8td28-ndWbYOnvpyt_cVejO-S2w5l02CjGLtky1V2y61ZyTV-6ctOv7pGvQ2vy6BK9lloBWDSzVU0lPCCFYFk35WUpdr4GN0evrudTPDvzml60RaBpkwBDRaXptVkKX7hSJ_fJeHT8-ejEdy0XfAWBw9JHdBekOo9TmfES-JVzbUCUXAnDylzHSpYpl4abSALwypguUyGYBJmKiEkdPyC9Cp5vj1Bud-CSIFBAFgVJBnGvCrOAsTzVOs89Eq95WyhXjxzbYkwLu8nGIS5pWFWgRAonEY_47ax5U4_jL_SHKLaWFqtp2z9mi8vCLc6CiSwohQLoU8JLiExqljBlGNheEyVGeeQJCr1oUlNbm1AME0w7ZjDPI88sBVbUqPDIzqVY1XXx_uOXfyC6OO8QvXBE5QzYoYRLk4B3wkpdHcqDDiXYBdUZ3kMVXXOlLqIoDwFdAkSEmWu13Tz8tB3Gm-IxPKt6SBMFOfYc8MjDRstbzsbYSSsKMo_wjv53WN8dqa6-2YLmKWcAlJNH_ynbfXIL4Ks98RemB6S3XKzMY4CIS9kn23zC4ZodhXgdveuTncPjs0_nffvRpW-twk_qQ2sK
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbtNAcFXCA7wgylVDoQsCAQ9uHXvttZEQCkfV0AOJHorEg9nLpVJqhzoR4qf4RmbWa4NRBbw0j9lZazwzO4d3DkIeF7EUURorP9E4wkxGEV4SCl9LDb8AFGCExcm7e8nWIXs_iSdL5EdbC4Npla1OtIpaVwq_kW-EYTYE2wgG7tXsq49To_B2tR2h0YjFtvn-DUK2-uX4LfD3SRhuvjt4s-W7qQK-At947qMDEyQ6ixKZ8gJkMOPaALZcCcOKTEdKFgmXhptQgm-RMl0kQjAJaIuQSR3Bcy-Ry2B4AzxRfNIFeKA7ksSV50V8uOGkYX1WlWYdbCVEHqxn_uyUgM4WDGbTqj7P0f0zX_M3A7h5nVxznisdNaK2TJZMeYMsO91Q02eugfXzm-TTyCpROkc7qBbgfppqUVMJCFIIv3XTsJbiLG0wnPTkdDbFbJwXdL9rK02bkhoqSk1PzVz4wjVPuUUOL4Tct8mgBPxWCOX2Ti8OAgVgYRCnEEmrYRowliVaZ5lHopa2uXIdznHQxjS313YcIp2GVDlyJHcc8Yjf7Zo1HT7-Af8a2dbBYn9u-0d1dpy7454zkQaFUOBMFfASIpWaxUwZBtrchLFRHllDpudNsWunZfJRjIXMDPZ55JGFwB4dJSYBHYtFXefjD0f_AbT_sQf01AEVFZBDCVd4Ae-Evb96kKs9SNA0qre8giLaUqXOf51J2NmK7fnLD7tlfCgm9lnRQ5gwyHCKgUfuNFLeUTbC2VxhkHqE9-S_R_r-SnnyxbZITzgD1zu--3e01siVrYPdnXxnvLd9j1wNMV3JZiqtksH8bGHug785lw_sIafk80VrlZ_Ys5WP
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkRAviPG1wGAGgYCHrGnixAkSQoVRbQwGYgxV4sH4K2NSl5SlFeJf46_jLnECQRPwsj7Wl8g-n393F98HIffzWMkojbWfGGxhpqIILwmlb5SBXwAAGGFy8pu9ZPuAvZrG0xXyo82FwbDKFhNroDalxm_kwzDMRqAbQcENcxcW8W5r8mz-1ccOUnjT2rbTaERk137_Bu5b9XRnC_b6QRhOXn54se27DgO-Bjt54aMxEyQmixKV8hzkMePGwsy5lpblmYm0yhOuLLehAjsjZSZPpGQKliBDpkwE7z1HzvMoHuEZ49PO2QMcSRKXqhfx0dBJxua8LOwm6E3wQlhPFdYdAzq9MJjPyuo0o_fP2M3flOHkMrnkrFg6bsRulazY4gpZdThR0UeumPXjq-TTuAZUukCdqJdgitpyWVEFE6TgipumeC3FvtqgROnR8XyGkTlP6H5XYpo26TVUFoYe24X0pSukco0cnAm7r5NBAfNbI5TX93txEGggC4M4Ba9aj9KAsSwxJss8ErW8FdpVO8emGzNRX-Fx8HoaVgncEeF2xCN-99S8qfbxD_rnuG0dLdbqrv8oTw6FO_qCyTTIpQbDKodFyFQZFjNtGSC7DWOrPbKBmy6axNcOccQ4xqRmBs955F5NgfU6CpT8Q7msKrHz9uN_EO2_7xE9dER5CezQ0iVhwJqwDliPcr1HCaije8NrKKItVyrx63zCk63Ynj58txvGl2KQXy16SBMGGXY08MiNRso7zkbYpysMUo_wnvz3WN8fKY6-1OXSE87ADI9v_n1aG-QC4Il4vbO3e4tcBLO4jiQcJetksDhZ2ttgei7UnfqMU_L5rEHlJ9Gumdg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Active+transcutaneous+bone+conduction+hearing+implants%3A+Systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Magele%2C+Astrid&rft.au=Schoerg%2C+Philipp&rft.au=Stanek%2C+Barbara&rft.au=Gradl%2C+Bernhard&rft.date=2019-09-16&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=14&rft.issue=9&rft.spage=e0221484&rft_id=info:doi/10.1371%2Fjournal.pone.0221484&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0221484
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon